HYPERLIPOPROTEINEMIA TYPE-III - IMMUNOLOGICAL DIAGNOSIS

被引：20
|
作者：
SEIDEL, D
GRETEN, H
机构：
来源：
CLINICA CHIMICA ACTA | 1970年 / 30卷 / 01期
关键词：
D O I：
10.1016/0009-8981(70)90189-0
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：31 / &
相关论文
共 50 条
  • [31] TYPE-III HYPERLIPOPROTEINEMIA WITH A RARE LIPOPROTEIN PHENOTYPE
    ZIEMER, A
    GORING, HD
    HAUTARZT, 1993, 44 (08): : 538 - 544
  • [32] ACUTE-PANCREATITIS IN TYPE-III HYPERLIPOPROTEINEMIA
    FEUSSNER, G
    INTERNIST, 1987, 28 (06): : 393 - 395
  • [33] ASSOCIATION OF APO E SUBCLASS BETA-IV WITH TYPE-III HYPERLIPOPROTEINEMIA (TYPE-III)
    BRESLOW, JL
    ZANNIS, VI
    TRACY, T
    GLUECK, CJ
    ARTERIOSCLEROSIS, 1981, 1 (01): : 82 - 82
  • [34] BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA
    MORGANROTH, J
    LEVY, RI
    FREDRICKSON, DS
    ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) : 158 - 174
  • [35] GEMFIBROZIL TREATMENT OF TYPE-III HYPERLIPOPROTEINEMIA (FAMILIAL DYSBETALIPOPROTEINEMIA)
    KUO, PT
    DETWILER, JG
    WILSON, AC
    ANGIOLOGY, 1986, 37 (10) : 775 - 776
  • [36] COMPARATIVE EFFECTS OF GEMFIBROZIL AND CLOFIBRATE IN TYPE-III HYPERLIPOPROTEINEMIA
    LARSEN, ML
    ILLINGWORTH, DR
    OMALLEY, JP
    ATHEROSCLEROSIS, 1994, 106 (02) : 235 - 240
  • [37] TYPE-III HYPERLIPOPROTEINEMIA - STUDY OF THE PATHOGENESIS AND THE EFFECT OF CLOFIBRATE
    STUYT, PMJ
    DEMACKER, PNM
    STALENHOEF, AFH
    SCHADE, RWB
    LUTTERMAN, JA
    VANTLAAR, A
    NETHERLANDS JOURNAL OF MEDICINE, 1979, 22 (05) : 171 - 172
  • [38] TYPE-III HYPERLIPOPROTEINEMIA - ANALYSIS OF 2 CONTEMPORARY DEFINITIONS
    FREDRICKSON, DS
    MORGANROTH, J
    LEVY, RI
    ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) : 150 - 157
  • [39] EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA IN AN ADOLESCENT PATIENT WITH HYPOTHYROIDISM
    LINDNER, MA
    ILLINGWORTH, DR
    JOURNAL OF PEDIATRICS, 1988, 113 (01) : 86 - 89
  • [40] METABOLISM OF CHYLOMICRONS IN SUBJECTS WITH DYSBETALIPOPROTEINEMIA (TYPE-III HYPERLIPOPROTEINEMIA)
    HAFFNER, SM
    KUSHWAHA, RS
    HAZZARD, WR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1989, 19 (05) : 486 - 490
12345